The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Open accessAbstract
The Zaire subtype of Ebola virus (EBO-Z) is lethal for newborn mice, but adult mice are resistant to the virus, which prevents their use as an animal model of lethal Ebola infection. We serially passed EBO-Z virus in progressively older suckling mice, eventually obtaining a plaque-purified virus that was lethal for mature, immunocompetent BALB/c and C57BL/6 inbred and ICR (CD-1) outbred mice. Pathologic changes in the liver and spleen of infected mice resembled those in EBO-Z-infected primates. Virus titers in these tissues reached 10(9) pfu/g. The LD50 of mouse-adapted EBO-Z virus inoculated into the peritoneal cavity was approximately 1 virion. Mice were resistant to large doses of the same virus inoculated subcutaneously, intradermally, or intramuscularly. Mice injected peripherally with mouse-adapted or intraperitoneally with non-adapted EBO-Z virus resisted subsequent challenge with mouse-adapted virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Textbook of Medical Physiology
(1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-6-1363_2 · Cited by 9,749
Sanchez, A., Trappier, S. G., Mahy, B. W., Peters, C. J., & Nichol, S. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3602 · Cited by 552
Sanchez, A., Kiley, M. P., Holloway, B. P., & Auperin, D. D. (1993) · Virus Research · doi:10.1016/0168-1702(93)90063-s · Cited by 318
Pathogenesis of Experimental Ebola Virus Infection in Guinea Pigs
Connolly, B. M., Steele, K. E., Davis, K. J., Geisbert, T. W., Kell, W. M., Jaax, N. K., & Jahrling, P. B. (1999) · The Journal of Infectious Diseases · doi:10.1086/514305 · Cited by 308
Self-citationDifferentiation of filoviruses by electron microscopy
Geisbert, T. W., & Jahrling, P. B. (1995) · Virus Research · doi:10.1016/0168-1702(95)00080-1 · Cited by 268
Self-citationISOLATION OF MARBURG-LIKE VIRUS FROM A CASE OF HÆMORRHAGIC FEVER IN ZAIRE
Pattyn, S., Groen, G. V., Jacob, W., Piot, P., & Courteille, G. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92002-5 · Cited by 196
Jahrling, P. B., Geisbert, J., Swearengen, J. R., Jaax, G. P., Lewis, T., Huggins, J. W., Schmidt, J. J., LeDuc, J. W., & Peters, C. J. (1996) · Imported Virus Infections · doi:10.1007/978-3-7091-7482-1_12 · Cited by 175
Self-citationMolecular biology and evolution of filoviruses
Feldmann, H., Klenk, H.-D., & Sanchez, A. (1993) · Archives of Virology · doi:10.1007/978-3-7091-9300-6_8 · Cited by 159
Ebola virus haemorrhagic fever
Pattyn, S. R. (1978) · Cited by 141
The pathology of experimental Ebola virus infection in monkeys
Baskerville, A., Bowen, E. T. W., Platt, G. S., et al. (1978) · The Journal of Pathology · doi:10.1002/path.1711250303 · Cited by 117
Cited by
Feldmann, H., & Geisbert, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60667-8 · Cited by 1,374
Self-citationEbola virus entry requires the cholesterol transporter Niemann–Pick C1
Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G., et al. (2011) · Nature · doi:10.1038/nature10348 · Cited by 1,303
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256
Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., Vega, M.-A. D. L., Soka, M. J., Wahl, V., Griffiths, A., Bollinger, L., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0147-3 · Cited by 664
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663
Strategies in the design of antiviral drugs
De Clercq, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 652
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Warren, T. K., Wells, J., Panchal, R. G., Stuthman, K. S., Garza, N. L., Van Tongeren, S. A., Dong, L., Retterer, C. J., Eaton, B. P., Pegoraro, G., et al. (2014) · Nature · doi:10.1038/nature13027 · Cited by 610
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
Geisbert, T. W., Hensley, L. E., Larsen, T., Young, H. A., Reed, D. S., Geisbert, J. B., Scott, D. P., Kagan, E., Jahrling, P. B., & Davis, K. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63591-2 · Cited by 576
Self-citationTwo-pore channels control Ebola virus host cell entry and are drug targets for disease treatment
Sakurai, Y., Kolokoltsov, A. A., Chen, C.-C., Tidwell, M. W., Bauta, W. E., Klugbauer, N., Grimm, C., Wahl-Schott, C., Biel, M., & Davey, R. A. (2015) · Science · doi:10.1126/science.1258758 · Cited by 555
Towner, J. S., Rollin, P. E., Bausch, D. G., Sanchez, A., Crary, S. M., Vincent, M., Lee, W. F., Spiropoulou, C. F., Ksiazek, T. G., Lukwiya, M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4330-4341.2004 · Cited by 515
Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation
Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., & Basler, C. F. (2006) · Journal of Virology · doi:10.1128/jvi.02349-05 · Cited by 463
Epitopes Involved in Antibody-Mediated Protection from Ebola Virus
Wilson, J. A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A. L., & Hart, M. K. (2000) · Science · doi:10.1126/science.287.5458.1664 · Cited by 459
Self-citationHuman asymptomatic Ebola infection and strong inflammatory response
Leroy, E., Baize, S., Volchkov, V., Fisher-Hoch, S., Georges-Courbot, M.-C., Lansoud-Soukate, J., Capron, M., Debré, P., Georges, A., & McCormick, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02405-3 · Cited by 411
The Pathogenesis of Ebola Virus Disease
Baseler, L., Chertow, D. S., Johnson, K. M., Feldmann, H., & Morens, D. M. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100506 · Cited by 404
Garbutt, M., Liebscher, R., Wahl-Jensen, V., Jones, S., Möller, P., Wagner, R., Volchkov, V., Klenk, H.-D., Feldmann, H., & Ströher, U. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5458-5465.2004 · Cited by 381
Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola
Towner, J. S., Khristova, M. L., Sealy, T. K., Vincent, M. J., Erickson, B. R., Bawiec, D. A., Hartman, A. L., Comer, J. A., Zaki, S. R., Ströher, U., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00069-06 · Cited by 378
Wauquier, N., Becquart, P., Padilla, C., Baize, S., & Leroy, E. M. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000837 · Cited by 377
Inflammatory responses in Ebola virus-infected patients
BAIZE, S., LEROY, E. M., GEORGES, A. J., GEORGES-COURBOT, M.-C., CAPRON, M., BEDJABAGA, I., LANSOUD-SOUKATE, J., & MAVOUNGOU, E. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01800.x · Cited by 370
FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection
Johansen, L. M., Brannan, J. M., Delos, S. E., Shoemaker, C. J., Stossel, A., Lear, C., Hoffstrom, B. G., DeWald, L. E., Schornberg, K. L., Scully, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005471 · Cited by 332
Ebola virus: from discovery to vaccine
Feldmann, H., Jones, S., Klenk, H.-D., & Schnittler, H.-J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1154 · Cited by 308
Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection
Maruyama, T., Rodriguez, L. L., Jahrling, P. B., Sanchez, A., Khan, A. S., Nichol, S. T., Peters, C. J., Parren, P. W. H. I., & Burton, D. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6024-6030.1999 · Cited by 293
Effective Post-Exposure Treatment of Ebola Infection
Feldmann, H., Jones, S. M., Daddario-DiCaprio, K. M., Geisbert, J. B., Ströher, U., Grolla, A., Bray, M., Fritz, E. A., Fernando, L., Feldmann, F., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030002 · Cited by 288
Self-citationJahrling, P. B., Geisbert, T. W., Geisbert, J. B., Swearengen, J. R., Bray, M., Jaax, N. K., Huggins, J. W., LeDuc, J. W., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514310 · Cited by 269
Self-citationPathogen-specific loss of host resistance in mice lacking the IFN-γ-inducible gene IGTP
Taylor, G. A., Collazo, C. M., Yap, G. S., Nguyen, K., Gregorio, T. A., Taylor, L. S., Eagleson, B., Secrest, L., Southon, E. A., Reid, S. W., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.751 · Cited by 265
Self-citationMarburg Virus Vaccines Based upon Alphavirus Replicons Protect Guinea Pigs and Nonhuman Primates
Hevey, M., Negley, D., Pushko, P., Smith, J., & Schmaljohn, A. (1998) · Virology · doi:10.1006/viro.1998.9367 · Cited by 262
Geisbert, T. W., Hensley, L. E., Kagan, E., Yu, E. Z., Geisbert, J. B., Daddario‐DiCaprio, K., Fritz, E. A., Jahrling, P. B., McClintock, K., Phelps, J. R., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/504267 · Cited by 254
Self-citationSaphire, E. O., Schendel, S. L., Fusco, M. L., Gangavarapu, K., Gunn, B. M., Wec, A. Z., Halfmann, P. J., Brannan, J. M., Herbert, A. S., Qiu, X., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.033 · Cited by 212
Persistent infection with Ebola virus under conditions of partial immunity
Gupta, M., Mahanty, S., Greer, P., Towner, J. S., Shieh, W.-J., Zaki, S. R., Ahmed, R., & Rollin, P. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.2.958-967.2004 · Cited by 85
Metadata
- Authors
- Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-09
- Volume
- 178
- Issue
- 3
- Pages
- 651-661
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2121706409
- Cited by
- 492
- References
- 12
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.